scai Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Search past issues
Search products and services

The OPTIMIZE randomized trial comparing a novel, low-profile drug-eluting stent (DES) facilitating transradial access and direct stenting to existing DES did not establish noninferiority of the new stent...

source: Cath Lab Digest

As much as intracoronary physiologic measures can help operators identify potential ischemia-producing targets for percutaneous coronary intervention (PCI), they may also verify whether the procedure — even when angiographic...

source: Medscape

The FlowTriever percutaneous mechanical thrombectomy system (Inari Medical) is safe and provides immediate benefits to patients with acute pulmonary embolism, interim results of the real-world FLASH registry suggest. Among the first 230 patients enrolled in the study, there...

source: TCTMD

A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease. The...

source: DAIC

Compare lung parenchymal and pulmonary artery (PA) growth and hemodynamics following early and delayed PA stent interventions for treatment of unilateral branch PA stenosis in swine. How the pulmonary...

source: Catheterization and Cardiovascular Interventions

Congenital left main coronary artery to right atrium fistulas with progression to aneurysm development are rare. Most patients remain asymptomatic, but for those with progressive symptoms, intervention is required.

source: Catheterization and Cardiovascular Interventions


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to SCAI This Week

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of SCAI? Yes   No
Privacy Policy